![](https://s3-eu-west-1.amazonaws.com/cjp-rbi-estatesgazette/wp-content/uploads/2023/10/Faraday-Hutton-and-Murdock-buildings-Reading-credit-Thames-Valley-Park-847-x-360-775x270.jpg)
Swiss pharma manufacturing firm Lonza has secured £30m of funding through the UK government’s Life Sciences Innovative Manufacturing Fund to expand and relocate into a specialist life sciences campus.
EG revealed last year that the Basel-headquartered firm
Thank you for reading EG
Want to read more? Enjoy a story a day for FREE for one month.